FocalTherics (FOCL) vs Cellyan Biotechnology Co., Ltd (HKPD)

FocalTherics and Cellyan Biotechnology Co., Ltd are both Medical Distribution companies. FocalTherics is the larger, with a market value of $172.0M against $17.1M — 10.1× the size. Across the 9 metrics below, Cellyan Biotechnology Co., Ltd leads on 7 and FocalTherics on 2.

Valuation

Metric FOCL HKPD Medical Distribution median
P/E n/m — —
P/S 2.15 — 0.23
P/B n/m n/m —
Price to free cash flow n/m n/m —
EV/EBITDA n/m n/m 15.49
EV/Sales 2.39 n/m 0.65
Earnings yield (21.87%) — (22.94%)
Free cash flow yield (11.43%) 0.00% (11.43%)

Profitability

Metric FOCL HKPD Medical Distribution median
Gross margin 44.53% — 8.01%
Operating margin (34.93%) — 0.46%
Net margin (50.11%) — (6.08%)
Free cash flow margin (24.60%) 0.00% 0.00%
Return on equity (133.48%) 0.00% 0.00%
Return on assets (50.28%) 0.00% 0.00%
Return on invested capital (110.75%) 0.00% 0.00%

Growth

Metric FOCL HKPD Medical Distribution median
Revenue growth (TTM) 29.45% — 11.54%
EPS growth (last fiscal year) (41.82%) (2,492.59%) —
Revenue growth, 5-year CAGR 8.18% — 8.18%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FOCL HKPD Medical Distribution median
Debt to equity (12.43) 0.10 (0.34)
Current ratio 1.60 3.86 1.05
Net debt to EBITDA (0.18) (0.79) (0.01)

Dividend

Metric FOCL HKPD Medical Distribution median
Dividend yield — — —
Payout ratio 0.00 — 0.00

Size

Metric FOCL HKPD Medical Distribution median
Market cap 172.03m 17.11m 172.03m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack